These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26474420)

  • 41. Gymnemagenin-producing endophytic fungus isolated from a medicinal plant Gymnema sylvestre R.Br.
    Parthasarathy R; Sathiyabama M
    Appl Biochem Biotechnol; 2014 Mar; 172(6):3141-52. PubMed ID: 24497046
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antihyperglycemic effects of gymnemic acid IV, a compound derived from Gymnema sylvestre leaves in streptozotocin-diabetic mice.
    Sugihara Y; Nojima H; Matsuda H; Murakami T; Yoshikawa M; Kimura I
    J Asian Nat Prod Res; 2000; 2(4):321-7. PubMed ID: 11249615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gymnema sylvestre for Diabetes: From Traditional Herb to Future's Therapeutic.
    Tiwari P; Ahmad K; Baig MH
    Curr Pharm Des; 2017; 23(11):1667-1676. PubMed ID: 27834124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Standardisation of Gymnema sylvestre r. Br. with reference to gymnemagenin by high-performance thin-layer chromatography.
    Puratchimani V; Jha S
    Phytochem Anal; 2004; 15(3):164-6. PubMed ID: 15202600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New hypoglycemic constituents in "gymnemic acid" from Gymnema sylvestre.
    Murakami N; Murakami T; Kadoya M; Matsuda H; Yamahara J; Yoshikawa M
    Chem Pharm Bull (Tokyo); 1996 Feb; 44(2):469-71. PubMed ID: 8998848
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A molecular connection of Pterocarpus marsupium, Eugenia jambolana and Gymnema sylvestre with dipeptidyl peptidase-4 in the treatment of diabetes.
    Kosaraju J; Dubala A; Chinni S; Khatwal RB; Satish Kumar MN; Basavan D
    Pharm Biol; 2014 Feb; 52(2):268-71. PubMed ID: 24074231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-inflammatory and immunomodulatory effects of Critonia aromatisans leaves: Downregulation of pro-inflammatory cytokines.
    la Torre Fabiola VD; Ralf K; Gabriel B; Victor Ermilo AA; Martha MG; Mirbella CF; Rocio BA
    J Ethnopharmacol; 2016 Aug; 190():174-82. PubMed ID: 27282666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel extract of Gymnema sylvestre improves glucose tolerance in vivo and stimulates insulin secretion and synthesis in vitro.
    Al-Romaiyan A; King AJ; Persaud SJ; Jones PM
    Phytother Res; 2013 Jul; 27(7):1006-11. PubMed ID: 22911568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An overview on the advances of Gymnema sylvestre: chemistry, pharmacology and patents.
    Porchezhian E; Dobriyal RM
    Pharmazie; 2003 Jan; 58(1):5-12. PubMed ID: 12622244
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gymnemic acids inhibit hyphal growth and virulence in Candida albicans.
    Vediyappan G; Dumontet V; Pelissier F; d'Enfert C
    PLoS One; 2013; 8(9):e74189. PubMed ID: 24040201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Larvicidal activity of Saponin isolated from Gymnema sylvestre R. Br. (Asclepiadaceae) against Japanese Encephalitis vector, Culex tritaeniorhynchus Giles (Diptera: Culicidae).
    Elumalai K; Dhanasekaran S; Krishnappa K
    Eur Rev Med Pharmacol Sci; 2013 May; 17(10):1404-10. PubMed ID: 23740457
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Abiotic elicitation of gymnemic acid in the suspension cultures of Gymnema sylvestre.
    Ch B; Rao K; Gandi S; Giri A
    World J Microbiol Biotechnol; 2012 Feb; 28(2):741-7. PubMed ID: 22806870
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gymnema sylvestre R. Br., an Indian medicinal herb: traditional uses, chemical composition, and biological activity.
    Di Fabio G; Romanucci V; Di Marino C; Pisanti A; Zarrelli A
    Curr Pharm Biotechnol; 2015; 16(6):506-16. PubMed ID: 25860062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Structural alterations in pancreatic islets in streptozotocin-induced diabetic rats treated with of bioactive additive on the basis of Gymnema sylvestre].
    Snigur GL; Samokhina MP; Pisarev VB; Spasov AA; Bulanov AE
    Morfologiia; 2008; 133(1):60-4. PubMed ID: 19069418
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sensory-Guided Multidimensional Exploration of Antisweet Principles from
    Pickrahn S; Dawid C; Babinger T; Schmid C; Brockhoff A; Meyerhof W; Hofmann T
    J Agric Food Chem; 2021 May; 69(19):5510-5527. PubMed ID: 33970622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Isolation and structure elucidation of gymnemic acids, antisweet principles of Gymnema sylvestre.
    Liu HM; Kiuchi F; Tsuda Y
    Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1366-75. PubMed ID: 1327559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunomodulatory effects of seabuckthorn (Hippophae rhamnoides L.) against chromium (VI) induced immunosuppression.
    Geetha S; Singh V; Ram MS; Ilavazhagan G; Banerjee PK; Sawhney RC
    Mol Cell Biochem; 2005 Oct; 278(1-2):101-9. PubMed ID: 16180095
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medicinal foodstuffs. X. Structures of new triterpene glycosides, gymnemosides-c, -d, -e, and -f, from the leaves of Gymnema sylvestre R. Br.: influence of gymnema glycosides on glucose uptake in rat small intestinal fragments.
    Yoshikawa M; Murakami T; Matsuda H
    Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):2034-8. PubMed ID: 9433774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In-silico analysis of gymnemagenin from Gymnema sylvestre (Retz.) R.Br. with targets related to diabetes.
    Rathore PK; Arathy V; Attimarad VS; Kumar P; Roy S
    J Theor Biol; 2016 Feb; 391():95-101. PubMed ID: 26711684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Triterpenoids from Gymnema sylvestre and their pharmacological activities.
    Fabio GD; Romanucci V; De Marco A; Zarrelli A
    Molecules; 2014 Jul; 19(8):10956-81. PubMed ID: 25072200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.